World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 12 February 2013
Main ID:  ISRCTN31707342
Date of registration: 03/03/2011
Primary sponsor: The National Children's Research Centre (Ireland)
Public title: Bag and mattress or bag for preterm infants in the delivery room: The Bambino Trial The Bambino Trial
Scientific title: Should exothermic mattresses be used in combination with polyethylene bags to prevent heat loss in preterm infants at birth? (bag and mattress or bag in the delivery room): a randomised controlled trial
Date of first enrolment: Jan 11 2011
Target sample size: 116
Recruitment status: Completed/Not recruiting
URL:  http://isrctn.org/ISRCTN31707342
Study type:  Interventional
Study design:  Randomised controlled trial  
Countries of recruitment
Ireland
Contacts
Name: Colm  O'Donnell
Address:  Neonatal Intensive Care Unit The National Maternity Hospital Holles Street 2 Dublin Ireland
Telephone:
Email: codonnell@nmh.ie
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Infants born at the National Maternity Hospital (NMH) at less than 31 weeks gestation by best obstetric estimate
Exclusion criteria: Known congenital anomaly with an open lesion (e.g. gastroschisis or myelomeningocele)

Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Prematurity/prevention of hypothermia in newborns
Intervention(s)
Infants in both groups will be placed in a polyethylene bag and placed under radiant heat after birth. Infants randomised to the "bag" group will receive no additional measures to provide heat. Infants randomised to "mattress group" will, in addition, be placed on an exothermic chemical mattress (TransWarmer® Infant Transport Mattress, Cooper Surgical Inc., Trumbull CT, USA) which will be activated before delivery.

The primary outcome for this trial is the infant's core (rectal) temperature on admission to the neonatal intensive care unit. All infants will be followed until hospital discharge.
Primary Outcome(s)
Core temperature 36.5 - 37.5°C on admission to the Neonatal Intensive Care Unit (NICU)
Secondary Outcome(s)
1. Apgar scores at 5 and 10 minutes
2. Positive pressure ventilation (PPV) in the delivery room (DR)
3. Intubation and mechanical ventilation in the DR
4. Supplemental oxygen in the DR
5. Chest compressions in the DR
6. Use of adrenaline and volume resuscitation in the DR
7. Time to NICU admission
8. Intubation and mechanical ventilation during hospital stay
9. Duration of oxygen therapy (hours and days)
10. Oxygen therapy at 28 days
11. Oxygen therapy at 36 weeks' corrected gestational age
12. Sepsis ? early and late onset
13. Patent ductus arteriosus
14. Intraventricular haemorrhage
15. Periventricular leukomalacia
16. Necrotising Enterocolitis
17. Hospital days
18. Death before hospital discharge
Secondary ID(s)
N/A
Source(s) of Monetary Support
The National Children's Research Centre (Ireland)
Secondary Sponsor(s)
N/A
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history